Partner News
The section includes updates from partner organizations on related advocacy efforts.
Materials in this section
European Harm Reduction Is Facing a Funding Crisis
Harm reduction has long been a cornerstone of European public health, being instrumental for the wellbeing of PWUD. However, in the last few years, the financial sustainability of many harm reduction initiatives has been under serious threat. More
Making the Next Five Years Count: Europe Not on Track to Reach 2030 SDG Targets on HIV, TB, Viral Hepatitis B and C and STIs
Although progress has been made towards the SDG target 3.3 to end the epidemics of HIV, TB, and combatting viral hepatitis B and C and STIs by 2030, EU/EEA is off track for many of the targets. More
Hepatitis C Epidemic Among Rohingya Refugees in Cox’s Bazar: A Public Health Emergency
International health organisations are struggling to respond to an alarming epidemic of hepatitis C in Rohingya refugees in Cox’s Bazar, Bangladesh. More
EHRC2024: Recordings of the Streamed Sessions Now Available Online
Thanks to Drugreporter, selected sessions were available to watch via streaming during the 6th European Harm Reduction Conference (EHRC2024), and their recordings can now be accessed online. More
INHSU 2024: Hepatitis C Key Takeaways
INHSU 2024 heard from global experts on innovative strategies to eliminate hepatitis C, including groundbreaking approaches to testing, treatment, and data collection. More
Accessible DAAs Shouldn’t Be DOA: Delivering on the Promise of Negotiated Price Reductions for HCV Treatment
The hepatitis C virus remains one of the deadliest infectious diseases, despite the existence of an effective eight-to-twelve week cure. Access to direct acting antivirals must be urgently expanded to save lives. More
WHO Prequalifies the First Self-Test for Hepatitis C Virus
WHO has prequalified the first HCV self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C. More
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
Test Enables Single-Visit Testing and Treatment for Hepatitis C. More
From Principle to Practice: Involving Communities in Research Design for Effective Hepatitis C Prevention
Unitaid’s funding to support the integration of hepatitis C testing and treatment in harm reduction services, while trialing the use of two underused products to prevent infection. More
ECDC: High Burden of Hepatitis B and C Persists in the EU/EEA
Recent ECDC data show that despite progress in prevention and control efforts, hepatitis B and C continue to pose significant public health challenges in the European Union and European Economic Area. More